VRS
AKBA icon

Virginia Retirement Systems’s Akebia Therapeutics AKBA Stock Holding History

Virginia Retirement Systems’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$137K Buy
+85,000
New +$178K ﹤0.01% 931
2022
Q1 		– Sell
-111,800
Closed -$253 – 1111
2021
Q4 		$253 Sell
111,800
-47,000
-30% -$128K ﹤0.01% 1010
2021
Q3 		$457K Buy
158,800
+102,400
+182% +$292K ﹤0.01% 806
2021
Q2 		$214K Buy
56,400
+9,600
+21% +$32.3K ﹤0.01% 982
2021
Q1 		$158K Buy
46,800
+26,400
+129% +$95.1K ﹤0.01% 1080
2020
Q4 		$57K Sell
20,400
-86,100
-81% -$251K ﹤0.01% 1093
2020
Q3 		$267K Sell
106,500
-5,300
-5% -$46.5K ﹤0.01% 959
2020
Q2 		$1.52M Sell
111,800
-40,900
-27% -$423K 0.02% 453
2020
Q1 		$1.16M Buy
152,700
+137,900
+932% +$1.07M 0.02% 496
2019
Q4 		$94K Sell
14,800
-7,700
-34% -$36.6K ﹤0.01% 1116
2019
Q3 		$88K Buy
+22,500
New +$96.4K ﹤0.01% 1095
2019
Q2 		– Sell
-16,200
Closed -$133K – 1115
2019
Q1 		$133K Buy
16,200
+2,500
+18% +$17.2K ﹤0.01% 1048
2018
Q4 		$76K Buy
+13,700
New +$107K ﹤0.01% 1044
2018
Q3 		– Sell
-141,100
Closed -$1.41M – 1028
2018
Q2 		$1.41M Buy
141,100
+102,600
+266% +$1.03M 0.02% 560
2018
Q1 		$367K Buy
+38,500
New +$539K ﹤0.01% 873

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virginia Retirement Systems's AKBA Position: Q4 2025 in Review

Virginia Retirement Systems opened a new position in Akebia Therapeutics (AKBA) in Q4 2025: 85,000 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #931 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in AKBA as recently as Q4 2021.

Virginia Retirement Systems first reported a position in AKBA in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.52M in Q2 2020. 165 funds tracked by Wall St. Rank hold AKBA as of Q4 2025.

  • Virginia Retirement Systems held 85,000 shares of Akebia Therapeutics worth $137K as of Q4 2025.
  • Akebia Therapeutics was a new Virginia Retirement Systems position in Q4 2025.
  • Akebia Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #931 holding.
  • Virginia Retirement Systems first reported a position in Akebia Therapeutics in Q1 2018 and has held it in 15 quarters since.
  • Virginia Retirement Systems's Akebia Therapeutics position peaked at $1.52M in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.